← Leaderboards
Samir S Mitragotri
University Of California Santa Barbara
$2,232,348
Attributed
$2,232,348
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $555.8K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,232,348 · 4
CDC$0 · 1
By mechanism
R01$1,579,022 · 2
R21$638,326 · 1
R13$15,000 · 1
R03$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyHourDosePharmaceutical PreparationsSafetyUltrasonographyOralHistologyInterestSurfactantAnimal ModelDiabetes MellitusCoculture TechniquesClinically RelevantDiabetic PatientDrug KineticsCarboxymethylcelluloseColorBaseControlled ReleaseCaprylatesAdhesivesBiological AvailabilityCustom
Grant awards (12)
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling$189,477
R21 · FY2017 · CA · contact PI
2017 Barrier Function of Mammalian Skin Gordon Research Conference$15,000
R13 · FY2017 · AR · contact PI
Orally bioactive exenatie and insulin for type II diabetes$323,363
R01 · FY2016 · DK · contact PI
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling$217,303
R21 · FY2016 · CA · contact PI
Orally bioactive exenatie and insulin for type II diabetes$324,303
R01 · FY2015 · DK · contact PI
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling$231,546
R21 · FY2015 · CA · contact PI
Orally bioactive exenatie and insulin for type II diabetes$302,397
R01 · FY2014 · DK · contact PI
Orally bioactive exenatie and insulin for type II diabetes$303,147
R01 · FY2013 · DK · contact PI
Cutaneous Gene Therapy with Ultrasound: DNA Vaccination$148,868
R01 · FY2006 · EB · contact PI
Cutaneous Gene Therapy with Ultrasound: DNA Vaccination$176,944
R01 · FY2005 · EB
A Novel and Non-Invasive Method of Dermal Sampling$0
R03 · FY2003 · OH
A Novel and Non-Invasive Method of Dermal Sampling$0
R03 · FY2002 · OH